AbCellera Biologics Inc. (ABCL) vs Arcutis Biotherapeutics, Inc. (ARQT)
- AbCellera Biologics Inc. ABCL 11.80 −6.94%
- Arcutis Biotherapeutics, Inc. ARQT 28.82 −0.96%
AbCellera Biologics Inc. and Arcutis Biotherapeutics, Inc. are both Biotechnology companies. AbCellera Biologics Inc. is the larger, with a market value of $4.1B against $3.7B — 1.1× the size. AbCellera Biologics Inc. has negative trailing earnings, so its P/E is not meaningful; Arcutis Biotherapeutics, Inc. trades at 131×. AbCellera Biologics Inc. grew revenue faster over the last twelve months: 101.3% against 76.1%. Arcutis Biotherapeutics, Inc. has the higher net margin (6.15% vs −248.8%) and the higher return on invested capital (23.6% vs −42.5%). Across the 17 metrics below, Arcutis Biotherapeutics, Inc. leads on 11 and AbCellera Biologics Inc. on 6.
Valuation
Profitability
| Metric | ABCL | ARQT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 91.14% | 65.16% |
| Operating margin | (340.25%) | 7.38% | 0.00% |
| Net margin | (248.82%) | 6.15% | 0.00% |
| Free cash flow margin | (180.84%) | 8.42% | 0.00% |
| Return on equity | (17.30%) | 15.86% | (56.36%) |
| Return on assets | (12.15%) | 6.78% | (48.04%) |
| Return on invested capital | (42.52%) | 23.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack